{"id":245716,"date":"2026-09-15T10:27:31","date_gmt":"2026-09-15T04:57:31","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=245716"},"modified":"2026-09-15T10:27:31","modified_gmt":"2026-09-15T04:57:31","slug":"orchid-pharma-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/orchid-pharma-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"Orchid Pharma Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"

Orchid Pharma share price Rs 1,000.20 on 15 September 2026, down 0.28%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 3.22 crore. Q2 FY26 base a loss of Rs 5.72 crore.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Orchid Pharma Q2 results date for FY27 is not confirmed, and Orchid Pharma Ltd. had not filed a board meeting intimation with the NSE or BSE as of 15 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 193.52 crore in revenue and a loss of Rs 5.72 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/p><\/div>\n

The Orchid Pharma Q2 results FY27 announcement is the next scheduled earnings event for Orchid Pharma Ltd.<\/a>, a maker of antibiotic active pharmaceutical ingredients, principally cephalosporins, along with finished formulations and a novel beta lactamase inhibitor programme, operating plants in Tamil Nadu and supplying regulated and emerging markets. The stock traded at Rs 1,000.20 on the NSE on 15 September 2026, down 0.28% from the previous close of Rs 1,003.05, about 11.7% below its 52-week high of Rs 1,133.00 and 108.4% above its 52-week low of Rs 480.00.<\/p>\n

What makes the Orchid Pharma Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 193.52 crore of revenue and a loss of Rs 5.72 crore, while the most recent quarter on record, Q1 FY27, produced Rs 304.17 crore and a profit of Rs 3.22 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n